Patents by Inventor Elodie MACHO FERNANDEZ

Elodie MACHO FERNANDEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200230164
    Abstract: The present invention relates to particulate entity, such as a nanoparticle or conjugate, for use in particular as adjuvant in vaccine or immunotherapy. More specifically, the invention relates to a particulate entity comprising: iv. an iNKT cell agonist such as ? Gal Car compound, and, v. one or more antigenic determinant(s) such as a tumour antigen(s) or pathogen-derived antigen(s), vi. a targeting agent that targets in vivo said iNKT cell agonist to dendritic cells, such as human BDCA3-dendritic cells.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 23, 2020
    Inventors: Francois TROTTEIN, Christelle FAVEEUW, Elodie MACHO FERNANDEZ, Luis Javier CRUZ RICONDO
  • Publication number: 20150374734
    Abstract: The present invention relates to particulate entity, such as a nanoparticle or conjugate, for use in particular as adjuvant in vaccine or immunotherapy. More specifically, the invention relates to a particulate entity comprising: iv. an iNKT cell agonist such as ? Gal Car compound, and, v. one or more antigenic determinant(s) such as a tumour antigen(s) or pathogen-derived antigen(s), vi. a targeting agent that targets in vivo said iNKT cell agonist to dendritic cells, such as human BDCA3+ dendritic cells.
    Type: Application
    Filed: February 20, 2014
    Publication date: December 31, 2015
    Inventors: Francois TROTTEIN, Christelle FAVEEUW, Elodie MACHO FERNANDEZ, Luis Javier CRUZ RICONDO